Recognition of the p53 Null Staining Pattern Increases the Detection of p53 Alterations in Inflammatory Bowel Disease-Associated Carcinomas

Colorectal cancer (CRC) occurring in the setting of Inflammatory Bowel Disease (IBD) is relatively uncommon. Mutations in p53 have been found in these cancers, and have been proposed as a possible genetic marker with utility in detection of these cancers and their precursor dysplasias. We undertook this study to determine the frequency of p53 null alterations, a recently observed pattern that has not previously been described in colitis-associated neoplasia.

View the poster

Choose Miraca for Your Patients


Learn more about Miraca's Anatomic Pathology services

Learn More »
TRADESHOWS >> FIND posters and presentations from past shows, and see where Miraca Life Sciences will be next.

Our use of EMA became exponentially more efficient once we partnered with Miraca.
— Rihanna Flanagan, PA-C,
Associates South Shore Dermatology, Quincy, Mass.


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.
Get news from Miraca. Join our email list.